Psychemedics Corporation provides hair sample-based drug testing services using patented technology that digests hair to release trapped drugs, followed by proprietary enzyme immunoassay (EIA) screening and mass spectrometry confirmation. Tests detect cocaine, marijuana, PCP, amphetamines, opioids, fentanyl, benzodiazepines, synthetic cannabinoids, nicotine, and alcohol. Services target employers, law enforcement, treatment professionals, school administrators, and parents. Testing is performed at their Culver City, California facility.
Analyzes hair samples for drugs of abuse including cocaine, marijuana, opioids, fentanyl, benzodiazepines, and more using patented EIA and mass spectrometry confirmation.
Hair Alcohol Testing
service
Measures average alcohol consumption over approximately three months via hair sample analysis, launched in 2013.
Solid Phase Multi-Analyte Assay (EIA)
service
Proprietary patented enzyme immunoassay procedure used to screen hair samples for drugs of abuse, FDA 510k cleared for nine assays.
Sectional Hair Analysis
service
Segments hair into sections corresponding to time periods to provide historical patterns of drug use.
Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking. AI Discovery Document | Registry Metrics | GitHub